Adenovirus type 7 vaccine, live 32,000 TCID50 Delayed Release Oral Tablet
RxNorm 1099940 NDC Crossover

NDC Directory Crossover & Product Mapping

The following National Drug Codes (NDCs) are directly associated with the clinical concept for Adenovirus type 7 vaccine, live 32,000 TCID50 Delayed Release Oral Tablet (RxCUI 1099940). This crossover tool provides a verified mapping between standardized RxNorm clinical drug definitions and the specific manufactured products listed in the FDA NDC directory.

Healthcare professionals, pharmacists, and data analysts use this list to identify various brand names, labelers, and commercial packaging variations linked to this semantic clinical drug concept. Each entry below represents a commercial product that fulfills the requirements of this specific clinical identifier.

Manufacturer Quick Index

→ Teva Women's Health, Inc. 1

Teva Women's Health, Inc.